HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

IFRA Monitoring Finds One Product Out Of Step With Its Code Of Practice

This article was originally published in The Rose Sheet

Executive Summary

The International Fragrance Association has uncovered one finished product that is not in compliance with its Code of Practice

You may also be interested in...



IFRA violator cleared

International Fragrance Association has determined the fragrance supplier fingered in July for using a banned material is in fact not in violation of the association's Code of Practice. IFRA discovered a product containing a prohibited substance during its third round of random testing (1"The Rose Sheet" July 13, 2009). Now it says the material in question was supplied before the material was banned under IFRA's standards and the fragrance supplier was fully compliant. Use of the material was discontinued after the ban was enacted, according to IFRA. "I am pleased that we have established that the fragrance house strictly adhered to the IFRA standards," says Jean-Pierre Houri, IFRA director general. "This incident demonstrates that the IFRA Compliance Program is robust and effective ensuring that IFRA standards are adhered to worldwide and that consumers can continue to enjoy the safe use of fragrances." IFRA's confidentiality policy prevents it from disclosing the substance, product, manufacturer or supplier involved. The group began an annual random test of 50 fragrance products from around the world in 2007; this was the first reported non-compliant product (2"The Rose Sheet" June 2, 2008)

IFRA violator cleared

International Fragrance Association has determined the fragrance supplier fingered in July for using a banned material is in fact not in violation of the association's Code of Practice. IFRA discovered a product containing a prohibited substance during its third round of random testing (1"The Rose Sheet" July 13, 2009). Now it says the material in question was supplied before the material was banned under IFRA's standards and the fragrance supplier was fully compliant. Use of the material was discontinued after the ban was enacted, according to IFRA. "I am pleased that we have established that the fragrance house strictly adhered to the IFRA standards," says Jean-Pierre Houri, IFRA director general. "This incident demonstrates that the IFRA Compliance Program is robust and effective ensuring that IFRA standards are adhered to worldwide and that consumers can continue to enjoy the safe use of fragrances." IFRA's confidentiality policy prevents it from disclosing the substance, product, manufacturer or supplier involved. The group began an annual random test of 50 fragrance products from around the world in 2007; this was the first reported non-compliant product (2"The Rose Sheet" June 2, 2008)

Fragrance Association Reports 100% Compliance With Industry Standards

The International Fragrance Association (IFRA) says 100 percent of member products analyzed in its second round of random testing - from May 2007 to April 2008 - are compliant with the trade group's Code of Practice

Latest Headlines
See All
UsernamePublicRestriction

Register

RS016277

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel